AZ-Pfizer relief: 'at risk' partnerships in the clear as takeover plans fold

Save

As the news breaks that UK big pharma AstraZeneca has rejected a final takeover bid from US giant Pfizer, several of both the firms' smaller pharma and biotech partners will be breathing a sigh of relief.